Billiontoone (NASDAQ:BLLN) Stock: Insider Bosch John Roderick Ten Sells 1,416 Shares

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of the firm’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $106.61, for a total value of $150,959.76. Following the completion of the sale, the senior vice president directly owned 23,635 shares in the company, valued at approximately $2,519,727.35. The trade was a 5.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $97.54, for a total transaction of $138,116.64.
• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total value of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00.

Billiontoone Trading Up 9.2%

BLLN opened at $124.90 on Friday. The firm has a market capitalization of $5.89 billion and a price-to-earnings ratio of 178.43. The company’s 50 day simple moving average is $108.87 and its two-hundred day simple moving average is $98.15. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million for the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. Analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.

Institutional Trading of Billiontoone

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BLLN. Adams Street Partners LLC purchased a new position in shares of Billiontoone during the fourth quarter worth approximately $140,063,000. Wasatch Advisors LP purchased a new stake in Billiontoone in the 1st quarter valued at $29,179,000. Capital International Investors purchased a new stake in Billiontoone in the 4th quarter valued at $14,568,000. Renaissance Technologies LLC acquired a new stake in Billiontoone during the 1st quarter worth $4,046,000. Finally, Emerald Advisers LLC grew its position in Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after purchasing an additional 50,613 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on BLLN. Guggenheim initiated coverage on shares of Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 price target on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Billiontoone in a research note on Friday, September 18th. Zacks Research lowered shares of Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. Canaccord Genuity Group began coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price target for the company. Finally, BTIG Research dropped their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Seven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $125.88.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.